Johan Jendle

Artiklar i tidskrifter

• Lind, A. , Cao, Y. , Hesser, H. , Hårdstedt, M. , Jansson, S. P. O. , Lernmark, Å. , Sundqvist, M. , Tevell, S. & et al. (2024). Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19.  Diabetes epidemiology and management, 13. [BibTeX]
• Hellman, J. , Hartvig, N. V. , Kaas, A. , Møller, J. B. , Sørensen, M. R. & Jendle, J. (2024). Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes.  Diabetes, obesity and metabolism, 26 (1), 301-310. [BibTeX]
• Benhalima, K. , Jendle, J. , Beunen, K. & Ringholm, L. (2024). Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where do we stand?.  Journal of Diabetes Science and Technology, 18 (6), 1334-1345. [BibTeX]
• Koçkaya, G. , Battelino, T. , Petrovski, G. , Jendle, J. , Sármán, B. , Elbarbary, N. , Gökşen, D. , Alharbi, M. & et al. (2024). Clinical perspective on innovative insulin delivery technologies in diabetes management.  Frontiers in Endocrinology, 15. [BibTeX]
• Eichenlaub, M. , Pleus, S. , Rothenbühler, M. , Bailey, T. S. , Bally, L. , Brazg, R. L. , Bruttomesso, D. , Diem, P. & et al. (2024). Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems.  Diabetes Technology & Therapeutics, 26 (4), 263-275. [BibTeX]
• Eichenlaub, M. , Stephan, P. , Waldenmaier, D. , Pleus, S. , Rothenbühler, M. , Haug, C. , Hinzmann, R. , Thomas, A. & et al. (2024). Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems.  Journal of Diabetes Science and Technology, 18 (4), 857-865. [BibTeX]
• Tian, T. , Aaron, R. E. , DuNova, A. Y. , Jendle, J. H. , Kerr, D. , Cengiz, E. , Drincic, A. , Pickup, J. C. & et al. (2024). Diabetes Technology Meeting 2023.  Journal of Diabetes Science and Technology, 18 (5), 1208-1244. [BibTeX]
• Sharif, A. , Smith, D. R. , Hellgren, K. & Jendle, J. (2024). Diabetic retinopathy among the elderly with type 2 diabetes: A Nationwide longitudinal registry study.  Acta Ophthalmologica, 102 (6), e883-e892. [BibTeX]
• Singh, R. , Imberg, H. , Ahmadi, S. S. , Hallström, S. , Jendle, J. , Tengmark, B. , Folino, A. , Marie, E. & et al. (2024). Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes.  Journal of Diabetes Science and Technology. [BibTeX]
• Szafranski, K. , De Pouvourville, G. , Greenberg, D. , Harris, S. , Jendle, J. , Shaw, J. E. , Coaquira Castro, J. , Poon, Y. & et al. (2024). The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation.  Value in Health, 27 (4), 500-507. [BibTeX]
• Klonoff, D. C. , Jendle, J. & Kohn, M. A. (2024). The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.  Journal of Diabetes Science and Technology, 18 (6), 1346-1361. [BibTeX]
• Pleus, S. , Eichenlaub, M. , Eriksson Boija, E. , Fokkert, M. , Hinzmann, R. , Jendle, J. , Klonoff, D. C. , Makris, K. & et al. (2024). The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring.  Journal of Diabetes Science and Technology. [BibTeX]
• Alexander, L. , Cheng-Ting, T. , Åke, L. & Jendle, J. (2024). Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients.  Journal of clinical & translational endocrinology, 37. [BibTeX]
• Jendle, J. , Buompensiere, M. I. , Ozdemir Saltik, A. Z. , de Portu, S. , Smith-Palmer, J. , Pollock, R. & Cohen, O. (2023). A European Cost-Utility Analysis of the MiniMedTM 780G Advanced Hybrid Closed-Loop System versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.  Diabetes Technology & Therapeutics, 25 (12), 864-876. [BibTeX]
• Klonoff, D. C. , Jendle, J. & Kovatchev, B. (2023). A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.  Journal of Diabetes Science and Technology, 17 (5), 1226-1242. [BibTeX]
• Jendle, J. (2023). Analysis of "Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States".  Journal of Diabetes Science and Technology, 17 (4), 959-961. [BibTeX]
• Persson, S. , Nilsson, K. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Steen Carlsson, K. (2023). Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital-based care, days absent from work, costs, and mortality.  Diabetes, obesity and metabolism, 53 (3), 726-734. [BibTeX]
• Scherbak, N. N. , Kruse, R. , Nyström, T. & Jendle, J. (2023). Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial.  Diabetes & metabolism journal, 47 (5), 668-681. [BibTeX]
• Scherbak, N. , Kruse, R. , Nyström, T. & Jendle, J. (2023). Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81).  Diabetes & metabolism journal, 47 (6), 882-883. [BibTeX]
• Heinemann, L. & Jendle, J. (2023). Language Matters: Connected Pens, Smart Pens, Connected Smart Pens, or Just Digital Pens?.  Journal of Diabetes Science and Technology, 17 (4), 875-877. [BibTeX]
• Nilsson, K. , Andersson, E. , Persson, S. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Steen Carlsson, K. (2023). Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease.  Diabetes, obesity and metabolism, 25 (3), 748-757. [BibTeX]
• Jendle, J. , Agvall, B. , Galozy, A. & Adolfsson, P. (2023). Patterns and Predictors Associated With Long-Term Glycemic Control in Pediatric and Young Adult Patients with Type 1 Diabetes.  Journal of Diabetes Science and Technology, 17 (5), 1243-1251. [BibTeX]
• Jendle, J. , Buompensiere, M. I. , Holm, A. L. , de Portu, S. , Malkin, S. J. P. & Cohen, O. (2022). A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.  Diabetes Therapy, 13 (5), 1125-1129. [BibTeX]
• Dobrosavljevic, M. , Fazel, S. , Du Rietz, E. , Li, L. , Zhang, L. , Chang, Z. , Jernberg, T. , Faraone, S. V. & et al. (2022). Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder.  Evidence-Based Mental Health, 25, 185-190. [BibTeX]
• Jendle, J. , Eeg-Olofsson, K. , Svensson, A. , Franzen, S. , Lamotte, M. & Levrat-Guillen, F. (2021). Cost-Effectiveness of the FreeStyle Libre^® System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden.  Diabetes Therapy, 12 (12), 3137-3152. [BibTeX]
• Jendle, J. H. , Ampudia-Blasco, F. J. , Füchtenbusch, M. & Pozzilli, P. (2021). Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination.  TouchREVIEWS in endocrinology, 17 (1), 12-20. [BibTeX]
• Sterner Isaksson, S. , Bensow Bacos, M. , Eliasson, B. , Thors Adolfsson, E. , Rawshani, A. , Lindblad, U. , Jendle, J. , Berglund, A. & et al. (2021). Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial.  BMJ Open Diabetes Research & Care, 9 (1). [BibTeX]
• Karlsson, J. , Galavazi, M. , Jansson, S. P. O. & Jendle, J. (2021). Effects on body weight, eating behavior, and quality of life of a low-energy diet combined with behavioral group treatment of persons with class II or III obesity: A 2-year pilot study.  Obesity Science & Practice, 7 (1), 4-13. [BibTeX]
• Mattsson, S. , Adolfsson, P. , Jendle, J. , Bengtsson, V. & Sparud-Lundin, C. (2021). Empowered by Intertwined Theory and Practice: Experiences From a Diabetes Sports Camp for Physically Active Adults With Type 1 Diabetes.  Frontiers in Clinical Diabetes and Healthcare, 2. [BibTeX]
• Jendle, J. & Jansson, S. P. O. (2021). Kontinuerlig glukosmätning alternativ vid typ 2-diabetes [Continuous glucose monitoring (CGM) in type 2 diabetes].  Läkartidningen, 118. [BibTeX]
• Jendle, J. , Hyötyläinen, T. , Oresic, M. & Nyström, T. (2021). Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.  Cardiovascular Diabetology, 20 (1). [BibTeX]
• Da Silva, J. , Bosi, E. , Jendle, J. , Arrieta, A. , Castaneda, J. , Grossman, B. , Cordero, T. L. , Shin, J. & et al. (2021). Real-world performance of the MiniMed™ 670G system in Europe.  Diabetes, obesity and metabolism, 23 (8), 1942-1949. [BibTeX]
• Sharif, A. , Jendle, J. & Hellgren, K. (2021). Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study.  Diabetes Therapy, 12 (1), 223-234. [BibTeX]
• Jendle, J. , Ericsson, Å. , Gundgaard, J. , Møller, J. B. , Valentine, W. J. & Hunt, B. (2021). Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis.  Diabetes Therapy, 12 (1), 373-388. [BibTeX]
• Jendle, J. , Buompensiere, M. I. , Holm, A. L. , de Portu, S. , Malkin, S. J. P. & Cohen, O. (2021). The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden.  Diabetes Therapy, 12 (11), 2977-2991. [BibTeX]
• Jendle, J. & Adolfsson, P. (2020). Continuous Glucose Monitoring Diving and Diabetes: An Update of the Swedish Recommendations.  Journal of Diabetes Science and Technology, 14 (1), 170-173. [BibTeX]
• Andersson, E. , Persson, S. , Hallén, N. , Ericsson, Å. , Thielke, D. , Lindgren, P. , Steen Carlsson, K. & Jendle, J. (2020). Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.  Diabetologia, 63 (12), 2582-2594. [BibTeX]
• Persson, S. , Johansen, P. , Andersson, E. , Lindgren, P. , Thielke, D. , Thorsted, B. L. , Jendle, J. & Carlsson, K. S. (2020). Days absent from work due to complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden.  Diabetes, obesity and metabolism, 22 (9), 1586-1597. [BibTeX]
• Groop, P. , Dandona, P. , Phillip, M. , Gillard, P. , Edelman, S. , Jendle, J. , Xu, J. , Scheerer, M. F. & et al. (2020). Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.  The Lancet Diabetes and Endocrinology, 8 (10), 845-854. [BibTeX]
• Huhn, E. A. , Linder, T. , Eppel, D. , Weißhaupt, K. , Klapp, C. , Schellong, K. , Henrich, W. , Yerlikaya-Schatten, G. & et al. (2020). Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial.  BMJ Open, 10 (11). [BibTeX]
• Jendle, J. , Ericsson, Å. , Ekman, B. , Sjöberg, S. , Gundgaard, J. , da Rocha Fernandes, J. , Mårdby, A. , Hunt, B. & et al. (2020). Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective.  Journal of Medical Economics, 23 (11), 1311-1320. [BibTeX]
• de Valk, H. W. , Feher, M. , Hansen, T. K. , Jendle, J. , Koefoed, M. M. , Rizi, E. P. , Zimmermann, E. & Fadini, G. P. (2020). Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study.  Diabetes Therapy, 11 (9), 2159-2167. [BibTeX]
• Jendle, J. (2020). The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.  Journal of Diabetes Science and Technology, 14 (4), 739-740. [BibTeX]
• Mattsson, S. , Jendle, J. & Adolfsson, P. (2019). Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1-An Exploratory Study.  Frontiers in Endocrinology, 10. [BibTeX]
• Jendle, J. , Pöhlmann, J. , de Portu, S. , Smith-Palmer, J. & Roze, S. (2019). Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.  Diabetes Technology & Therapeutics, 21 (3), 110-118. [BibTeX]
• Jendle, J. & Riddell, M. C. (2019). Editorial: Physical Activity and Type 1 Diabetes.  Frontiers in Endocrinology, 10. [BibTeX]
• Nyström, T. , Santos-Pardo, I. , Fang, X. , Cao, Y. , Hedberg, F. & Jendle, J. (2019). Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group study.  Endocrinology, Diabetes & Metabolism, 2 (2). [BibTeX]
• Jendle, J. , Birkenfeld, A. L. , Polonsky, W. H. , Silver, R. , Uusinarkaus, K. , Hansen, T. , Håkan-Bloch, J. , Tadayon, S. & et al. (2019). Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials.  Diabetes, obesity and metabolism, 21 (10), 2315-2326. [BibTeX]
• Fadini, G. P. , Feher, M. , Hansen, T. K. , de Valk, H. W. , Koefoed, M. M. , Wolden, M. , Zimmerman, E. & Jendle, J. (2019). Switching to Degludec from Other Basal Insulins is Associated with Reduced Hypoglycemia Rates: a Prospective Study.  Journal of Clinical Endocrinology and Metabolism, 104 (12), 5977-5990. [BibTeX]
• Jendle, J. , Sandberg, A. , Buchs, S. , Swinburn, P. , Hadi, M. & Levin, L. Å. (2018). A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes.  Journal of Patient-Reported Outcomes, 2 (20). [BibTeX]
• Jendle, J. , Ericsson, Å. , Hunt, B. , Valentine, W. J. & Pollock, R. F. (2018). Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.  Diabetes Therapy, 9 (1), 87-99. [BibTeX]
• Jendle, J. , Fang, X. , Cao, Y. , Bojö, L. , Nilsson, B. , Hedberg, F. , Santos-Pardo, I. & Nyström, T. (2018). Effects on repetitive 24-hour ambulatory blood pressure in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment both in combination with metformin: A randomized open parallel-group study.  Journal of the American Society of Hypertension : JASH, 12 (5), 346-355. [BibTeX]
• Nyström, T. , Santos-Pardo, I. , Hedberg, F. , Wardell, J. , Witt, N. , Cao, Y. , Bojö, L. , Nilsson, B. & et al. (2018). Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study (vol 8, 325, 2017).  Frontiers in Endocrinology, 9. [BibTeX]
• Jendle, J. & Heinemann, L. (2018). Real-Time Continuous Glucose Monitoring Usage in Pilots with Diabetes: An Option to Improve Safety.  Diabetes Technology & Therapeutics, 20 (7), 453-454. [BibTeX]
• Jendle, J. , Smith-Palmer, J. , Delbaere, A. , de Portu, S. , Papo, N. , Valentine, W. & Roze, S. (2017). Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden.  Diabetes Therapy, 8 (5), 1015-1030. [BibTeX]
• Mattsson, S. , Adolfsson, P. & Jendle, J. (2017). Diabetes Sports Camps for Individuals with Type 1 Diabetes Associated with Improved Glycemic Control and Self-Estimated Level of Knowledge.  Journal of Diabetes Research and Therapy, 3 (2). [BibTeX]
• Nyström, T. , Santos, I. P. , Hedberg, F. , Wardell, J. , Witt, N. , Cao, Y. , Bojo, L. , Nilsson, B. & et al. (2017). Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study.  Frontiers in Endocrinology, 8. [BibTeX]
• Jendle, J. , Rinnert, K. , Westman, A. & Heinemann, L. (2017). Pilots and Diabetes Technology: Functional Health.  Journal of Diabetes Science and Technology, 11 (2), 191-194. [BibTeX]
• Jendle, J. , Testa, M. A. , Martin, S. , Jiang, H. & Milicevic, Z. (2016). Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.  Diabetes, obesity and metabolism, 18 (10), 999-1005. [BibTeX]
• Ridderstrale, M. , Evans, L. M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, Å. & Jendle, J. (2016). Estimating the impact of changes in HbA(1c), body weight and insulin injection regimen on health related quality-of-life: a time trade off study.  Health and Quality of Life Outcomes, 14. [BibTeX]
• Roze, S. , Gherardi, A. , de Portu, S. & Jendle, J. (2016). Health-Economic Analysis Of The Use Of Sensor-Augmented Pump With Predictive Suspend Function (Sap) Therapy In Sweden Compared To Insulin Pump Therapy Alone (Csii), In Type 1 Diabetic Patients.  Value in Health, 19 (7), A699-A699. [BibTeX]
• Jendle, J. H. , Rawshani, A. , Svensson, A. , Avdic, T. & Gudbjörnsdóttir, S. (2016). Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control.  Journal of Diabetes Science and Technology, 10 (5), 1027-1033. [BibTeX]
• Adolfsson, P. , Strömgren, A. , Mattsson, S. , Chaplin, J. E. & Jendle, J. (2015). Education and individualized support regarding exercise and diabetes improves glucose control and level of physical activity in type 1 diabetes individuals.  Journal of Endocrinology Diabetes & Obesity, 3 (2), 1071-1077. [BibTeX]
• Adolfsson, P. , Mattsson, S. & Jendle, J. (2015). Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes.  European Journal of Applied Physiology, 115 (12), 2599-2607. [BibTeX]
• Roze, S. , Saunders, R. , Brandt, A. -. , de Portu, S. , Papo, N. L. & Jendle, J. (2015). Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.  Diabetic Medicine, 32 (5), 618-626. [BibTeX]
• Steineck, I. , Cederholm, J. , Eliasson, B. , Rawshani, A. , Eeg-Olofsson, K. , Svensson, A. , Zethelius, B. , Avdic, T. & et al. (2015). Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study.  BMJ-BRITISH MEDICAL JOURNAL, 350. [BibTeX]
• Blonde, L. , Jendle, J. , Gross, J. , Woo, V. , Jiang, H. , Fahrbach, J. L. & Milicevic, Z. (2015). Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.  The Lancet, 385 (9982), 2057-2066. [BibTeX]
• Yousef, M. , Westman, A. , Lindberg, A. , de Lacerda, C. & Jendle, J. (2014). Glucose Changes and Working Memory in Individuals with Type 1 Diabetes During Air Pressure Changes Simulating Skydiving.  Diabetes Technology & Therapeutics, 16 (1), 56-62. [BibTeX]
• Khalili, P. , Sundström, J. , Jendle, J. , Lundin, F. , Jungner, I. & Nilsson, P. M. (2014). Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: The Värmland survey.  Primary Care Diabetes, 8 (4), 352-357. [BibTeX]
• Freemantle, N. , Meneghini, L. , Christensen, T. , Wolden, M. L. , Jendle, J. & Ratner, R. (2013). Insulin degludec improves health-related quality of life (SF-36(®) ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.  Diabetic Medicine, 30 (2), 226-232. [BibTeX]
• Khalili, P. , Sundström, J. , Franklin, S. S. , Jendle, J. , Lundin, F. , Jungner, I. & Nilsson, P. M. (2012). Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37 843 individuals.  Journal of Hypertension, 30 (9), 1718-1724. [BibTeX]
• Adolfsson, P. , Örnhagen, H. , Eriksson, B. M. , Cooper, K. & Jendle, J. (2012). Continuous glucose monitoring: a study of the Enlite sensor during hypo- and hyperbaric conditions.  Diabetes Technology & Therapeutics, 14 (6), 527-532. [BibTeX]
• Valentine, W. J. , Jendle, J. , Saraheimo, M. , Thorsteinsson, B. , Pollock, R. F. & Lammert, M. (2012). Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.  Diabetic Medicine, 29 (3), 303-312. [BibTeX]
• Lind, M. , Jendle, J. , Torffvit, O. & Lager, I. (2012). Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction.  Primary Care Diabetes, 6 (1), 41-46. [BibTeX]
• Home, P. D. , Meneghini, L. , Wendisch, U. , Ratner, R. E. , Johansen, T. , Christensen, T. E. , Jendle, J. , Roberts, A. P. & et al. (2012). Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes.  Diabetic Medicine, 29 (6), 716-720. [BibTeX]
• Adolfsson, P. , Ornhagen, H. , Eriksson, B. M. , Gautham, R. & Jendle, J. (2012). In-vitro performance of the Enlite sensor in various glucose concentrations during hypobaric and hyperbaric conditions.  Journal of Diabetes Science and Technology, 6 (6), 1375-1382. [BibTeX]
• Jendle, J. , Christensen, J. H. , Kvistgaard, H. , Gregersen, N. & Rittig, S. (2012). Late-onset familial neurohypophyseal diabetes insipidus due to a novel mutation in the AVP gene.  Clinical Endocrinology, 77 (4), 586-592. [BibTeX]
• Jendle, J. , Alvarsson, M. , Hanås, R. & Attvall, S. (2012). Mätning av blodketoner [Measuring blood ketones]: när, var och hur [when, where and how].  Läkartidningen, 109 (45), 2031-2032. [BibTeX]
• Jendle, J. , Adolfsson, P. & Ornhagen, H. (2012). Swedish recommendations on recreational diving and diabetes mellitus.  Diving and Hyperbaric Medicine, 42 (4), 231-233. [BibTeX]
• Jendle, J. , Torffvit, O. , Ridderstråle, M. , Ericsson, Å. , Nilsen, B. & Bøgelund, M. (2012). Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results.  Journal of Medical Economics, 15 (Suppl 2), 1-5. [BibTeX]
• Jendle, J. , Ridderstråle, M. , Torfvitt, O. , Ericsson, Å. & Larsen, S. (2012). Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes.  Journal of Medical Economics, 15 (2), 261-263. [BibTeX]
• Jendle, J. , Adolfsson, P. , Attvall, S. & Örnhagen, H. (2011). Dykning vid diabetes möjligt men inte riskfritt [Diving in diabetes possible but not without risks].  Läkartidningen, 108 (44), 2230-2231. [BibTeX]
• Jendle, J. & Adolfsson, P. (2011). Impact of high altitudes on glucose control.  Journal of Diabetes Science and Technology, 5 (6), 1621-1622. [BibTeX]
• Birkeland, K. I. , Home, P. D. , Wendisch, U. , Ratner, R. E. , Johansen, T. , Endahl, L. A. , Lyby, K. , Jendle, J. & et al. (2011). Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.  Diabetes Care, 34 (3), 661-665. [BibTeX]
• Faerch, M. , Corydon, T. J. , Rittig, S. , Christensen, J. H. , Hertz, J. M. & Jendle, J. (2010). Skewed X-chromosome inactivation causing diagnostic misinterpretation in congenital nephrogenic diabetes insipidus.  Scandinavian Journal of Urology and Nephrology, 44 (5), 324-330. [BibTeX]
• Khalili, P. , Flyvbjerg, A. , Frystyk, J. , Lundin, F. , Jendle, J. , Engström, G. & Nilsson, P. M. (2010). Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study.  Diabetes & Metabolism, 36 (2), 137-143. [BibTeX]
• Jendle, J. , Torffvit, O. , Ridderstråle, M. , Lammert, M. , Ericsson, Å. & Bøgelund, M. (2010). Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes.  Current Medical Research and Opinion, 26 (4), 917-923. [BibTeX]
• Adolfsson, P. , Örnhagen, H. & Jendle, J. (2009). Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational diving.  Diabetes Technology & Therapeutics, 11 (8), 493-497. [BibTeX]
• Jendle, J. (2009). Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved.  International journal of clinical practice (Esher), 63 (7), 980-982. [BibTeX]
• Jendle, J. , Nauck, M. A. , Matthews, D. R. , Frid, A. , Hermansen, K. , During, M. , Zdravkovic, M. , Strauss, B. J. & et al. (2009). Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.  Diabetes, obesity and metabolism, 11 (12), 1163-1172. [BibTeX]
• Goodall, G. , Jendle, J. , Valentine, W. J. , Munro, V. , Brandt, A. B. , Ray, J. A. , Roze, S. , Foos, V. & et al. (2008). Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.  International journal of clinical practice (Esher), 62 (6), 869-876. [BibTeX]
• Adolfsson, P. , Örnhagen, H. & Jendle, J. (2008). The benefits of continuous glucose monitoring and a glucose monitoring schedule in individuals with type 1 diabetes during recreational diving.  Journal of Diabetes Science and Technology, 2 (5), 778-784. [BibTeX]
• Jendle, J. & Norberg, B. (2007). Kliniska erfarenheter av behandling med Levemir [Clinical experiences with Levemir treatment]..  Läkartidningen, 104 (1-2), 54-54. [BibTeX]
• Kølendorf, K. , Ross, G. P. , Pavlic-Renar, I. , Perriello, G. , Philotheou, A. , Jendle, J. , Gall, M. & Heller, S. R. (2006). Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.  Diabetic Medicine, 23 (7), 729-735. [BibTeX]
• Himmelmann, A. , Jendle, J. , Mellén, A. , Petersen, A. H. , Dahl, U. L. & Wollmer, P. (2003). The impact of smoking on inhaled insulin.  Diabetes Care, 26 (3), 677-682. [BibTeX]
• Brunner, G. A. , Balent, B. , Ellmerer, M. , Schaupp, L. , Siebenhofer, A. , Jendle, J. , Okikawa, J. & Pieber, T. R. (2001). Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients..  Diabetologia, 44 (3), 305-308. [BibTeX]
• Lundström, A. , Jendle, J. , Stenström, B. , Toss, G. & Ravald, N. (2001). Periodontal conditions in 70-year-old women with osteoporosis.  Swedish Dental Journal, 25 (3), 89-96. [BibTeX]
• Jendle, J. , Karlberg, B. E. & Arborelius, M. (1996). An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs.  Scandinavian Journal of Clinical and Laboratory Investigation, 56 (3), 251-258. [BibTeX]
• Jendle, J. & Karlberg, B. E. (1996). Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes.  Scandinavian Journal of Clinical and Laboratory Investigation, 56 (6), 555-561. [BibTeX]
• Jendle, J. & Karlberg, B. E. (1996). Intrapulmonary administration of insulin to healthy volunteers.  Journal of Internal Medicine, 240 (2), 93-98. [BibTeX]
• Jendle, J. , Karlberg, B. E. , Persliden, J. , Franzén, L. & Arborelius, M. (1995). Delivery and Retention of an Insulin Aerosol Produced by a New Jet Nebulizer.  Journal of Aerosol Medicine, 8 (3), 243-254. [BibTeX]
• Nilsson, L. , Nilsson, M. & Jendle, J. (1988). Subpopulations of variants resistant to imipenem in Pseudomonas aeruginosa.  Journal of Antimicrobial Chemotherapy, 22 (5), 643-649. [BibTeX]

Artiklar, forskningsöversikter

• Jendle, J. , Adolfsson, P. , Choudhary, P. , Dovc, K. , Fleming, A. , Klonoff, D. C. , Mader, J. K. , Oliver, N. & et al. (2024). A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.  Diabetologia, 67 (2), 236-245. [BibTeX]
• Adolfsson, P. , Hanas, R. , Zaharieva, D. P. , Dovc, K. & Jendle, J. (2024). Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review.  Journal of Diabetes Science and Technology, 18 (6), 1324-1333. [BibTeX]
• von Kobyletzki, L. B. , Ulriksdotter, J. , von Kobyletzki, E. , Mowitz, M. , Jendle, J. & Svedman, C. (2024). Insulin Pump Therapy and Adverse Skin Reactions With Focus on Allergic Contact Dermatitis in Individuals Living With Diabetes Mellitus: A Systematic Review and Clinical-Based Update.  Journal of Diabetes Science and Technology, 18 (6), 1300-1312. [BibTeX]
• Freckmann, G. , Eichenlaub, M. , Waldenmaier, D. , Pleus, S. , Wehrstedt, S. , Haug, C. , Witthauer, L. , Jendle, J. & et al. (2023). Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.  Journal of Diabetes Science and Technology, 17 (6), 1506-1526. [BibTeX]
• Garcia-Argibay, M. , Li, L. , Du Rietz, E. , Zhang, L. , Yao, H. , Jendle, J. , Ramos-Quiroga, J. A. , Ribasés, M. & et al. (2023). The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study.  Neuroscience and Biobehavioral Reviews, 147. [BibTeX]
• Jendle, J. & Reznik, Y. (2023). Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.  Diabetes, obesity and metabolism, 25 (Sup. 2), 21-32. [BibTeX]
• Jendle, J. , Landin, B. , Jansson, S. P. O. & Nordin, G. (2020). När HbA1c inte stämmer: Olika metoder kan ge olika resultat – och ibland kan även resultat som stämmer överens ge fel bild av glukosbalansen.  Läkartidningen, 117 (37). [BibTeX]
• Jendle, J. , Adolfsson, P. & Pollock, N. W. (2020). Recreational diving in persons with type 1 and type 2 diabetes: Advancing capabilities and recommendations.  Diving and Hyperbaric Medicine, 50 (2), 135-143. [BibTeX]
• Jendle, J. , Grunberger, G. , Blevins, T. , Giorgino, F. , Hietpas, R. T. & Botros, F. T. (2016). Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program.  Diabetes/Metabolism Research Reviews, 32 (8), 776-790. [BibTeX]
• Jendle, J. , Martin, S. A. & Milicevic, Z. (2012). Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review.  Expert Opinion on Investigational Drugs, 21 (10), 1463-1474. [BibTeX]

Böcker

• Venizelos, N. , Sirsjö, A. , Ericsson, E. , Johansson, M. , Hjelmqvist, H. , Jendle, J. , Eriksson, M. , Karlsson, M. & et al. Venizelos, N. (ed.) , Sirsjö, A. (ed.) , Ericsson, E. (ed.) , Johansson, M. (ed.) , Hjelmqvist, H. (ed.) , Jendle, J. (ed.) , Eriksson, M. (ed.) , Karlsson, M. (ed.) & Möller, M. (ed.) (2018). Örebro University’s Nobel Day Festivities: Book of abstracts, 2018. Örebro: Örebro universitet. [BibTeX]

Kapitel i böcker, del av antologier

• Jendle, J. & Törnberg, Å. (2021). Fysisk aktivitet vid typ 1 diabetes. I: Ing-Mari Dohrn, Eva Jansson Mats Börjesson, Maria Hagströmer, Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling, FYSS 2021 (ss. 325-330). Stockholm: Läkartidningen Förlag AB. [BibTeX]
• Jendle, J. & Törnberg, Å. (2021). Fysisk aktivitet vid typ 2 diabetes. I: Ing-Mari Dohrn, Eva Jansson Mats Börjesson, Maria Hagströmer, Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling, FYSS 2021 (ss. 331-336). Stockholm: Läkartidningen Förlag AB. [BibTeX]
• Jendle, J. (2020). Insulinbehandling. I: Mona Landin Olsson, Diabetes (ss. 107-118). Lund: Studentlitteratur AB. [BibTeX]
• Jendle, J. (2016). Diabetes Melitus: Typ 1-diabetes, Typ 2-diabetes. I: Maria Hagströmer, Eva Jansson, FYSS 2017: Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling (ss. 371-390). Stockholm: Läkartidningen Förlag AB. [BibTeX]

Konferensbidrag

• Jendle, J. , Buompensiere, M. I. , Saltik, A. Z. O. & Cohen, O. (2023). COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES ACROSS EUROPE. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid Advanced Technologies & Treatments for Diabetes Conference, Berlin, Germany, February 22-25, 2023. (ss. A119-A119). Mary Ann Liebert. [BibTeX]
• Menzen, M. , Hartvig, N. V. , Kaas, A. , Knudsen, N. & Jendle, J. (2023). FACTORS AFFECTING BASAL INSULIN INJECTION ADHERENCE INVESTIGATED USING SMART INSULIN PEN DATA. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid Advanced Technologies & Treatments for Diabetes Conference, Berlin, Germany, February 22-25, 2023. (ss. A197-A197). Mary Ann Liebert. [BibTeX]
• Sharif, A. , Jendle, J. & Hellgren, K. (2023). Inter-observer Reliability of Counting Retinal Microaneurysms and Haemorrhages in Elderly with Diabetes. I:  European Journal of Ophthalmology. Konferensbidrag vid 33rd European Association for Diabetic Eye Complications Conference (EAsDEC 2023), Coimbra, Portugal, June 1–3, 2023. (ss. 20-20). Sage Publications. [BibTeX]
• Jendle, J. , Agvall, B. , Galozy, A. & Adolfsson, P. (2022). BETTER GLYCEMIC CONTROL AND HIGHER USE OF ADVANCED DIABETES TECHNOLOGY IN AGE GROUP 0-17 YRS COMPARED TO 18-25 YRS WITH TYPE 1 DIABETES. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), Barcelona, Spain, April 27-30, 2022. (ss. A127-A127). Mary Ann Liebert. [BibTeX]
• Hellman, J. , Hartvig, N. V. , Kaas, A. , Møller, J. B. , Sørensen, M. R. & Jendle, J. (2022). INFLUENCE OF BOLUS INJECTION DOSING FREQUENCY AND SMART PEN ENGAGEMENT ON GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), Barcelona, Spain, April 27-30, 2022. (ss. A64-A65). Mary Ann Liebert. [BibTeX]
• Coaquira, C. J. , De Pouvourville, G. , Greenberg, D. , Harris, S. , Jendle, J. , Shaw, J. E. , Levrat, G. F. & Szafranski, K. (2022). INTERNAL, EXTERNAL, AND CROSS-VALIDATION OF THE DEDUCE MODEL, A COST-UTILITY TOOL USING PATIENT-LEVEL MICROSIMULATION TO EVALUATE SENSOR-BASED GLUCOSE MONITORING SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES. I:  Value in Health. Konferensbidrag vid ISPOR Europe 2022, Vienna, Austria, November 6-9, 2022. (ss. S11-S11). ELSEVIER SCIENCE INC. [BibTeX]
• Persson, S. , Nilsson, K. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Carlsson, K. S. (2021). Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: hospital-based care, days absent from work, costs, and mortality. I:  Diabetologia. Konferensbidrag vid 57th EASD Annual Meeting of the European Association for the Study of Diabetes, September 27 – October 1, 2021. (ss. 17-17). Springer. [BibTeX]
• Cohen, O. , Holm, A. L. , Buompensiere, M. I. & Jendle, J. (2021). COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE 1 DIABETES IN SWEDEN. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid ATTD Advanced Technologies & Treatments for Diabetes Conference, (Virtual conference), June 2-5, 2021. (ss. A81-A81). Mary Ann Liebert. [BibTeX]
• Carlsson, K. S. , Andersson, E. , Persson, S. , Hallén, N. , Ericsson, Å. , Thielke, D. , Lindgren, P. & Jendle, J. (2020). Costs of diabetes complications: hospital based care and production loss for 392,200 people with type 2 diabetes and matched controls in Sweden. I:  Diabetologia. Konferensbidrag vid 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (ss. S121-S121). Springer. [BibTeX]
• Hunt, B. , Ericsson, Å. , Gundgaard, J. , Møller, J. B. , Valentine, W. J. & Jendle, J. (2020). Evaluating the long-term cost-effectiveness of introducing a smart insulin pen in standard-of-care treatment of type 1 diabetes in Sweden. I:  Diabetologia. Konferensbidrag vid 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (ss. S381-S381). Springer. [BibTeX]
• Catrina, S. , Hartvig, N. , Kaas, A. , Møller, J. , Mårdby, A. -. & Jendle, J. (2020). Type 1 diabetes: analysis of real-world insulin injection patterns. I:  Diabetologia. Konferensbidrag vid 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (ss. S378-S378). Springer. [BibTeX]
• Jendle, J. , de Portu, S. & Roze, S. (2019). Cost effectiveness analysis of MiniMed 670G system versus continuous subcutaneous insulin infusion, in individuals with type 1 diabetes. Konferensbidrag vid ATTD 2019, Berlin, Germany, 20-23 February, 2019. [BibTeX]
• Jendle, J. , Edelman, S. , Dandona, P. , Mathieu, C. , Thoren, F. , Scheerer, J. , Xu, J. & Langkilde, A. (2019). Dapagliflozin as an adjunct to insulin on urinary albumin-to creatinine ratio over 52 weeks in adults with type 1 diabetes. Konferensbidrag vid ATTD 2019, Berlin, Germany, 20-23 February, 2019. [BibTeX]
• Jendle, J. , Edelman, S. , Dandona, P. , Mathieu, C. , Thoren, F. A. , Scheerer, M. F. , Xu, J. & Langkilde, A. M. (2019). EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES. I:  Diabetes Technology & Therapeutics. Konferensbidrag vid Advanced Technologies & Treatments for Diabetes Conference (ATTD), Berlin, Germany, February 20–23, 2019. (ss. A136-A137). Mary Ann Liebert. [BibTeX]
• Lahtela, J. , Edelman, S. , Jendle, J. , Dandona, P. , Mathieu, C. , Thorén, F. , Scheerer, M. , Xu, J. & et al. (2019). Effect of adding dapagliflozin as an adjunct to insulin on urinary albumin-to-creatinine ratio over 52 weeks in adults with type 1 diabetes. Konferensbidrag vid 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (ss. S342-S342). Springer. [BibTeX]
• Feher, M. , Fadini, G. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Hypoglycaemia, irrespective of the definition used, is reduced when switching to insulin degludec from other basal insulins in routine clinical care: The ReFLeCT study. Konferensbidrag vid 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (ss. S385-S385). Springer. [BibTeX]
• Jendle, J. , Thunander, M. , Sjöberg, S. , Ekman, B. , Mårdby, A. , da Rocha Fernandes, J. D. , Gundgaard, J. & Ericsson, Å. (2019). Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting. Konferensbidrag vid 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (ss. S436-S436). Springer. [BibTeX]
• Fadini, G. P. , Feher, M. , Hansen, T. K. , de Valk, H. W. , Koefoed, M. M. , Wolden, M. , Zimmermann, E. & Jendle, J. (2019). Reduced rates of overall hypoglycaemia in patients with Type 1 diabetes after switching to insulin degludec: A European, multinational, multicentre, prospective, observational study (ReFLeCT). I:  Diabetic Medicine. Konferensbidrag vid Diabetes UK Professional Conference 2019, Liverpool, UK, March 6-8, 2019. (ss. 60-60). John Wiley & Sons. [BibTeX]
• de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycaemia across patient subgroups in routine clinical care: The ReFLeCT study. Konferensbidrag vid EASD 2019, Barcelona, Spain, 16-20 September, 2019. [BibTeX]
• de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycemia (according to different definitions) in routine clinical care: The ReFLeCT Study. Konferensbidrag vid ADA 2019, San Francisco, CA, USA, 7-11 June, 2019. [BibTeX]
• de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycemia across patient subgroups in routine clinical care: The ReFleCT study. Konferensbidrag vid ADA2019, San Francisco, CA, USA, 7-11 June, 2019. [BibTeX]
• Jendle, J. , Thunander, M. , Ekman, B. , Sjöberg, S. , Ericsson, Å. , da Rocha Fernandes, J. , Mårdby, A. , Malkin, S. & et al. (2019). Switching to insulin degludec is a cost-saving therapy for patients with type 1 and type 2 diabetes in the Swedish setting based on real world data. I:  Value in Health. Konferensbidrag vid ISPOR 2019, Copenhagen, Denmark, November 2-6, 2019. (ss. 575-576). Elsevier. [BibTeX]
• Sharif, A. , Jendle, J. & Hellgren, K. J. (2018). Compliance to Screening of Diabetic Retinopathy with 18 to 36 Months Interval. I:  European Journal of Ophthalmology. Sage Publications. [BibTeX]
• Galavazi, M. , Jansson, S. P. O. , Jendle, J. & Karlsson, J. (2018). Long-term effects of low energy diet combined with CBT-based group treatment of patients with obesity on weight, quality of life and eating behaviour: a 2-year intervention study. Konferensbidrag vid IOB, Vienna, Austria, 2018. [BibTeX]
• Jendle, J. , Birkenfeld, A. L. , Silver, R. , Uusinarkaus, K. , Højbjerre, L. , Thomsen, H. F. & Davies, M. (2017). Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes. I:  Value in Health. Elsevier. [BibTeX]
• Klinkenbijl, B. , Jendle, J. , Chaugule, S. & Graham, C. (2017). Evaluation Of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (Rtcgm) Versus Self Monitoring Of Blood Glucose (Smbg) Alone In Type 1 Diabetes From The Swedish Societal Perspective. I:  Value in Health. Konferensbidrag vid ISPOR 2107. (ss. A585-A585). Elsevier. [BibTeX]
• Jendle, J. , Testa, M. , Martin, S. , Jiang, H. & Milicevic, Z. (2015). Continuous glucose monitoring in type 2 diabetes patients treated with once weekly dulaglutide or once daily glargine, both combined with insulin lispro (AWARD-4 substudy). I:  Diabetologia. Konferensbidrag vid 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, September 14-18, 2015. (ss. S38-S38). [BibTeX]
• Jendle, J. , Ridderstrale, M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, A. & Evans, M. (2015). Investigating the short-term impact of poor glycemic control on the daily lives of people with type 2 diabetes. I:  Value in Health. [BibTeX]
• Evans, M. , Ridderstråle, M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, Å. & Jendle, J. (2015). Quantifying The Short-Term Impact of Changes In Hba1c, Weight And Insulin Regimen on Health Related Quality-of-Life. I:  Value in Health. Elsevier. [BibTeX]
• Jendle, J. , Blonde, L. , Rosenstock, J. , Woo, V. , Gross, J. , Jiang, H. & Milicevic, Z. (2014). Better glycaemic control and less weight gain with once weekly dulaglutide vs bedtime insulin glargine, both combined with thrice daily lispro, in type 2 diabetes (AWARD-4). I:  Diabetologia. [BibTeX]

Manuskript

• Khalili, P. , Sundström, J. , Jendle, J. , Jungner, I. & Nilsson, P. M. Siliac-acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort : the Värmland survey. [BibTeX]

Samlingsverk (redaktör)

• Jendle, J. (ed.) , Riddell, M. C. (ed.) & Jones, T. W. (ed.) (2019). Physical Activity and Type 1 Diabetes (1ed.). Lausanne: Frontiers Media S.A.. [BibTeX]